PPE could be safely decontaminated and reused to conserve supplies and save waste, say engineers

  • Advice published on critical issues for reprocessing of single-use PPE for critical shortages as second wave of Covid-19 infection looms and government publishes its PPE strategy
  • Government encouraged to pursue more sustainable use of PPE as pandemic continues

Serious consideration should be given to decontaminating and reusing some types of PPE in order to maintain supplies and reduce waste, provided it can be safely reprocessed and suitable quality assurance procedures established, according to a paper published today by the National Engineering Policy Centre. The paper, following the government’s publication of its PPE Strategy for England, was drawn up following international consultation with engineers and manufacturers in other countries where various methods of reprocessing have been tested and evaluated.

With a winter surge in Covid-19 cases looming across the UK, the NHS should consider developing appropriate reprocessing facilities, the paper says. This would need to be done in consultation with experts across the delivery pipeline to ensure all the component parts including validated reprocessing facilities, logistics, and the provision of skilled personnel can scale simultaneously to meet potential demand.

Over 2 billion items of PPE were delivered to the health and social care system in England alone between March and July 2020, including over 400 million masks, 300 million aprons, 4 million gowns and half a billion pairs of gloves. The UK has rapidly scaled domestic PPE manufacturing capability, with UK-based supply anticipated to meet 70% of forecasted demand in December for all categories of PPE, excluding gloves – by far the biggest component of PPE by number. However, this may be tested by the challenges of winter if there are sustained periods of high transmission rates and increased hospital admissions or supply disruptions due to adverse weather events and the end of the EU transition period. The paper outlines how reprocessing could help to reduce pressure on supplies.

The potential decontamination methods detailed in the paper have been studied and trialled in the US, China, Finland, Japan and Germany, including treatment with hydrogen peroxide vapour, ultraviolet light, moist heat, dry heat and irradiation. The method of decontamination chosen would determine which items of PPE were applicable, necessary validations, potential risks and how many times the PPE could be reprocessed. Adopting a standardised approach across the UK would be beneficial.

Quality management records for any decontamination methods adopted would be critical to ensure good practice, traceability, and auditability alongside robust health and safety protocols to assess and manage risk assessments. Rigorous validation and verification would be required of any approach to the reprocessing of single use PPE to ensure that the PPE decontamination process was effective and did not introduce other risks. This would include assessments to ensure the elimination of Sars-CoV-2 and other micro-organisms, quantitative fit tests and performance tests.  Any soiled or damaged PPE has to be disposed of appropriately and reprocessed PPE must be tracked to ensure that that reuse does not exceed the recommended number of cycles.

Healthcare professionals would need to be consulted to ensure that the risks of reprocessing PPE are fully understood and any process deployed should be validated locally but remain under review as scientific evidence continues to emerge.

Professor David Delpy CBE FREng FRS FMedSci, a Fellow of the Royal Academy of Engineering, says:

“We welcome the government’s PPE strategy, which outlines how it aims to move away from disposable by default and assess new types of PPE that are designed for reuse from the outset. Some UK pilot studies are now in progress.

“However, as the pandemic continues, we think there should be more emphasis on decontamination methods, which if properly used could enable more sustainable use of PPE that is specifically designed for reuse and reprocessing. We need to be conscious of the environmental impact of using and disposing of so much plastic waste, particularly when much of it has to be incinerated after use.

“It is vital to ensure that critical care workers have access to PPE if there is another sustained period of high Covid-19 transmission and emergency reprocessing of single-use PPE should not be seen as an alternative to increasing the supply of vital protective clothing and equipment for our frontline staff.”

Notes for Editors

1.    The National Engineering Policy Centre commentary on considerations for PPE reprocessing based on international practices was developed in consultation with Fellows of the Royal Academy of Engineering, experts in the Institution of Chemical Engineers, the Institute of Healthcare Engineering and Estate Management, the Institution of Engineering Designers, the Institute of Physics and Engineering in Medicine, the International Society for Pharmaceutical Engineering UK Affiliate and through the Academy’s international networks with other engineering Academies.

2.    National Engineering Policy Centre

We are a unified voice for 43 professional engineering organisations, representing 450,000 engineers, a partnership led by the Royal Academy of Engineering.

We give policymakers a single route to advice from across the engineering profession.

We inform and respond to policy issues of national importance, for the benefit of society.

3.    The Royal Academy of Engineering is harnessing the power of engineering to build a sustainable society and an inclusive economy that works for everyone.

In collaboration with our Fellows and partners, we’re growing talent and developing skills for the future, driving innovation and building global partnerships, and influencing policy and engaging the public.

Together we’re working to tackle the greatest challenges of our age.

For more information please contact:

Jane Sutton at the Royal Academy of Engineering

T: 0207 766 0636

E:  Jane Sutton

By |2020-10-04T23:01:00+00:00October 4th, 2020|Engineering News|Comments Off on PPE could be safely decontaminated and reused to conserve supplies and save waste, say engineers

Academy invests £22 million in emerging technologies that could have global benefits

Academy’s largest funding scheme selects eight global visionaries

The Royal Academy of Engineering has announced that eight engineering academics at universities across the UK are to receive support from its largest research funding scheme—the Chairs in Emerging Technologies. A total of £22 million has been allocated to support these innovative researchers and global leaders in their fields whose projects made it through the rigorous selection process in the face of stiff competition.

Research being funded this year includes the development of electronic textiles; multifunctional composites that could revolutionise sectors from aerospace to portable electronic devices; and machine learning techniques that could improve the sustainability of the chemical industry and help to reduce the £20 billion of waste produced globally during the manufacture of medicines.

Other projects will use novel materials in semiconductors to improve energy efficiency; find new ways to deal with nuclear waste; and improve the delivery of clean drinking water and wastewater treatment in rural communities. Our future healthcare also stands to gain from the development of new biosensing technology platforms.

Professor Sir Jim McDonald FREng FRSE, President of the Royal Academy of Engineering, said: “When I see such exciting projects as these, I am genuinely heartened and optimistic about the engineering talent we have working in this country and the critical role our engineers can play in helping to tackle global challenges. These visionary engineers and the projects they will be working on are outstanding examples of why the Academy places such importance on supporting excellence in engineering as part of its strategy to achieve a sustainable society and inclusive economy that works for everyone. We expect great things of them all and I’m confident they will deliver results that will benefit the economy and society as a whole.”

The Chairs in Emerging Technologies scheme is made possible through funding from the UK’s Department for Business, Energy & Industrial Strategy (BEIS). The eight Chairs and their research projects are:

 

Professor Stephen Beeby, University of Southampton
Electronic textiles engineering: towards invisible and ubiquitous wearable technologies

Professor Beeby will develop electronic textiles into a practical platform technology for wearable applications and beyond. His research will exploit printed active materials, flexible circuit technologies and textile engineering to integrate sensing, electronic and energy harvesting/storage functionality within a single textile. This will create reliable e-textile systems that are invisible to the user and require minimal intervention for a range of health and work-related applications.

 

 

Professor Emile Greenhalgh, Imperial College London
Structural power and multifunctional structural materials

Professor Emile Greenhalgh will develop structural power composites, which are mechanically load-bearing materials that can also store and deliver electrical energy. These multifunctional composites are a completely new way of using structural materials, heralding an emerging technology that could revolutionise sectors such as aerospace, automotive, portable electronics and infrastructure. If successful, such ‘massless energy’ could ultimately consign conventional batteries to history.

 

 

Professor Jonathan Hirst, University of Nottingham
Machines learning chemistry

Professor Hirst will develop machine learning techniques to help chemical engineers and chemists make their manufacturing processes more sustainable. Working with scientists at the University of Nottingham’s Centre for Sustainable Chemistry, Professor Hirst aims to build interactive machine learning models of sustainability that can be used early in the discovery phase by researchers in the pharmaceutical sector and related chemical-based industries.

 

 

Professor Martin Kuball, University of Bristol
Ultra-wide bandgap emerging power electronics for a low-carbon economy

Professor Kuball wants to develop a new class of semiconductor power electronic devices using ultra-wide bandgap materials such as gallium oxide, boron nitride and aluminium nitride. Thanks to the outstanding properties of these materials, the new devices will be compact, highly versatile and energy efficient. This new generation of power electronics is the key to transforming a wide range of real-life applications from data centres and motor drives to electric vehicle chargers to smart grids.

 

 

Professor Bruno Merk, University of Liverpool
iMAGINE – a breakthrough technology to make more out of spent nuclear fuel

Professor Merk aims to develop an advanced nuclear technology to turn spent fuel, currently declared as nuclear waste, into an asset that can be used as fuel for future nuclear reactors without the expensive reprocessing technologies currently used at Sellafield. His innovative approach could significantly reduce the cost of nuclear energy, reduce the amount of nuclear waste for disposal and create a valuable net-zero energy resource for future generations. He will work with key industrial stakeholders and government institutions to develop this technology.

 

 

Professor Douglas Paul, University of Glasgow
Single-chip cold-atom systems: a quantum navigator in your mobile phone

Professor Paul aims to develop cold-atom atomic clocks, accelerometers and rotation sensors that can be manufactured on single silicon chips and used for navigation without relying on satellites. Laser light is already used to slow atoms down by quantum processes and reduce their temperature close to absolute zero, enabling accurate atomic clocks and quantum sensors. However, present systems are large, heavy and expensive and his research aims to develop chip-scale quantum navigators that can fit inside a mobile phone and could enable resilient position, navigation and timing systems for all forms of transport.

 

Professor William Sloan, University of Glasgow
Off-grid water biotechnologies

Professor Bill Sloan will develop new technologies to simultaneously tackle the most pressing global water problems and help decarbonise the water industry. Some 35% of the world’s population, most of whom live in rural communities, lack access to either improved sanitation or safe drinking water. The western, centralised model for water supply and treatment is too energy- and capital-intensive to deliver sustainable solutions. Professor Sloan will harness the bioprocessing power of microorganisms to deliver clean drinking water and treat wastewater in rural communities using low-energy, sustainable, off-grid technologies.

 

Professor Molly Stevens FREng FRS, Imperial College London
Multidimensional Target-Agnostic Sensing (MTAS): the next generation of biosensors

The Stevens Group is very active in the development of bioengineering strategies for the biosensing and regenerative medicine fields. Professor Stevens aims to develop next-generation biosensing technology platforms, including a new MTAS platform. Working closely with clinical and industrial partners, her research will enable applications in point-of-care diagnostics, disease profiling and monitoring of biotech processes.

 

 


Notes for Editors

  1. The Academy’s Chair in Emerging Technologies scheme aims to identify global research visionaries and provide them with long-term support to lead on developing emerging technology areas with high potential to deliver economic and social benefit to the UK.
     

For more information please contact: Pippa Cox at the Royal Academy of Engineering Tel. 020 7766 0745; email: Pippa.Cox@raeng.org.uk

By |2020-10-01T23:01:00+00:00October 1st, 2020|Engineering News|Comments Off on Academy invests £22 million in emerging technologies that could have global benefits

The Biotechnological Potentials of Bacteria Isolated from Parsık Cave, Turkey

Caves are dark environments with high humidity, low nutrients, stable temperature and high mineral diversity. They are natural geological formations constituting ecological niches for microorganisms (1). Each cave is singular in its physical, chemical, biological and ecological factors. These conditions contribute to the formation of unique microbial communities in every cave. Moreover, caves contain some unique microorganisms which lead to rock weathering process and biomineralisation by carrying out various enzymatic reactions as a result of their metabolism. These microorganisms play an important and major role in the formation of cave structures such as stalactites, stalagmites, cave pearls and curtains (25). Studies have shown that cave isolates have biotechnological and industrial applications such as microplastic degradation (6), biological treatment of metal contaminated soil and groundwater (7) and use in self-healing concrete (8).

The insufficient nutrient levels in caves stimulate competition among microorganisms by forcing them to develop survival strategies such as producing high amounts of exopolymeric substances, enzymes and antimicrobial metabolites. Hence, caves could be considered as incomparable environments for the discovery of new antibiotics and production of novel enzymes (911).

Since microorganisms have the capacity to produce a high quantity of stable enzymes in a short period of time, they become the preferred source of industrial enzymes. Microbial enzymes are used in the clinical field for diagnosis, treatment, biochemical tests and monitoring of various diseases. Furthermore, cave microbial enzymes are used in biotechnological and industrial fields such as biodegradation, recycling of waste (12), purification and dirt or waste-dissolving products. It is reported that enzymes from microorganisms isolated from cold cave or ocean environments offer economic benefits and contribute to energy conservation due to their activation at low temperatures (13, 14).

Apart from the importance of enzymes isolated from cave microorganisms, it is interesting to investigate the potential of producing new antimicrobial agents. Since the World Health Organization pointed out the need for new antibiotics because of increasing microbial resistance (15), studies in this field are multiplying and many cave isolates producing antimicrobial substances have been discovered. Cervimycin A, B, C and D from Streptomyces tendae strain HKI 0179 isolated from Grotta dei Cervi in Italy (16), Xiakemycin A from Streptomyces sp. CC8-201 isolated from Chongqing City karst soil in China (17), and Hypogeamicin A, B, C and D from Nonomuraea specus isolated from Hardin’s cave system in Tennessee, USA (18) were the first produced and purified bioactive substances from microorganisms of caves situated in different geographical regions.

Bacteria in environments far away from human influence are not expected to have antibiotic resistance. However, studies have shown that bacteria isolated from such environments do have antibiotic resistance. Some bacteria have resistance genes by which they can produce neutralising or detoxifying products which act against microorganisms in the same environment. This explains the imperative production of antibiotics in these bacteria. Since the resistance and antimicrobial biosynthesis genes are often linked and coregulated, antibiotic resistance in environmental bacteria remains a major indicator of antibiotic production, as is the case of bacteria isolated from soil (19, 20). Therefore, it is important to establish antibiotic resistance profiles as well as the antibacterial properties of bacteria.

This study has two main goals:

  • Detection of enzyme profiles of the isolates and determination of isolates that have potential uses in biotechnology

  • Investigation of antimicrobial agents and antibiotic resistance of cave bacteria.

2.1 Studying Area and Sampling

Parsık cave is located in Izmit-Aksığın village (Global Positioning System (GPS) coordinates 40° 37′ 50.1060″N, 29° 57′ 56.5056″E), in the north-west of Turkey. It is a horizontal cave with a length of 778 m and a depth of 166 m. There is an intense water inlet in Parsık cave throughout four seasons. Samples were taken from water, soil and surface formations (‘moonmilk’) (Figure 1). The selected sampling zones are the sole area away from the entrance area, trip and running water pathway. Although Parsık cave is not a show cave, it is open to cavers and researchers.

Fig. 1

Map of Parsık cave (red dots show the sampling areas) from the Anatolian Speleology Association, Turkey

Map of Parsık cave (red dots show the sampling areas) from the Anatolian Speleology Association, Turkey

Surface formation samples were collected by sterile swabs under aseptic conditions and cultivated on starch casein agar (SCA), inorganic salt-starch agar (ISP4), soil extract agar (SEA) and Actinomycetes isolation agar (AIA-G) in duplicate for each region. Once the plates reached the laboratory, they were incubated aerobically for a period of 5–30 days at 20°C (21). All water and soil samples were taken in sterile sample containers.

2.2 Physicochemical Measurements of Sampling Areas

Humidity and temperature values of the sampling areas were measured by a portable temperature/humidity meter. In addition, the temperature, conductivity, amount of dissolved substances and pH values of the sampled water sources were measured during sampling and recorded by a HQ40D digital two channel multimeter (Hach Lange GmbH, Germany).

2.3 Total (Live/Dead) Bacteria Number

The redox dye 5-cyano-2,3-ditolyl-tetrazolium chloride (CTC) was used together with the DNA-binding fluorescent dye 4,6-diamidino-2-phenylindole (DAPI) to determine the total number of bacterial cells and the viable count of bacteria which actively respire. The concept is to distinguish between the metabolically active cells and the dead cells present in each of the water and soil samples. The experimentation procedure is the same as previously described by Güngör and Yurudu (22).

2.4 Enumeration and Isolation of Culturable Aerobic Heterotrophic Bacteria

1 l of water samples were condensed by using polyamide filters of 0.22 μm pore size. Filters were re-suspended in 20 ml of sterile physiological saline water. 1 g of the soil samples was homogenised in 9 ml of sterile physiological saline water. All samples were cultivated using the 10-fold serial dilution method. Diluted samples were cultured on tap water agar (TWA) and Reasoner’s 2A agar (R2A) for enumeration and isolation of bacteria from water and soil samples. In addition, bacterial isolation from soil samples was on SCA, ISP4, AIA-G, SEA and 1/2 tryptic soy agar (TSA) media, and that from water samples was on 1/2 TSA only.

Plates were incubated aerobically for a period of 5–30 days at 20°C (21). At the end of incubation, plates which contained between 30 and 300 colonies were considered for both soil and water samples. Colonies which appeared different were selected for identification, then stored at −86°C for subsequent uses.

2.5 Identification of Cave Isolates and Their Enzymatic Reactions

Cave isolates were identified through biochemical tests performed in the VITEK® 2 system (bioMérieux SA, France). One of the three formats of this system is the VITEK® 2 Compact 30 which focuses mainly on the industrial microbiology-testing environment. Based on this industrial software, three reagent cards of VITEK® 2 Compact 30, named Gram-negative fermenting and non-fermenting bacilli (GN), Gram-positive cocci and non-spore-forming bacilli (GP) and Gram-positive spore-forming bacilli (BCL), were used to characterise the isolated bacteria following the procedure and data given by the system manufacturers. Reagent cards are based on established biochemical methods and developed substrates (23). The results of biochemical reactions were interpreted to establish enzymatic profiles of isolates.

2.6 Ability of Cave Bacteria to Produce Antimicrobial Materials

The ability of Bacilli or Actinobacteria to produce antimicrobial agents was tested on standard strains of fungi species of Candida albicans (ATCC® 10231TM) and bacterial species of Escherichia coli (ATCC® 8739TM), Pseudomonas aeruginosa (ATCC® 9027TM), Staphylococcus aureus (ATCC® 6538TM), Bacillus subtilis (ATCC® 6633TM), Staphylococcus epidermidis (ATCC® 12228TM), Klebsiella pneumoniae (ATCC® 4352TM), Enterococcus hirae (ATCC® 10541TM), vancomycin-resistant Enterococcus faecalis (VRE) (ATCC® 51299TM) and methicillin-resistant Staphylococcus aureus (MRSA) (ATCC® 33591TM).

Bacterial suspensions containing 3 × 108 cells ml−1 of the selected isolates were prepared. 2.5 μl of each suspension were incubated on Mueller Hinton Agar (MHA) plates at 20°C for 24 h. After incubation, all media in which bacterial colonies were observed, were exposed to ultraviolet (UV) radiation in an open laminar flow cabinet. Therefore, the vitality of the bacteria was destroyed. 1.5 × 108 cells ml−1 of 24 h fresh cultures of the standard strains were prepared. 100 μl of each suspension was mixed with TSA medium at 45°C. Subsequently, it was poured into the previously UV exposed plates, then incubated for 24 hours at 37°C after solidification. At the end of the incubation period, the growth of the standard bacteria in the TSA was investigated and the zone diameters were measured (24).

2.7 Susceptibility to Antibiotics

The sensitivity of 101 selected isolates to antibiotics was examined by using the disc diffusion method of Kirby-Bauer (21) in which 10 antibiotics were used: piperacillin (100 μg), erythromycin (15 μg), vancomycin (30 μg), ampicillin (10 μg), neomycin (10 μg), gentamycin (10 μg), chloramphenicol (30 μg), tetracycline (10 μg), rifampicin (30 μg) and ofloxacin (10 μg). The incubation conditions were 24 h at 20°C. Escherichia coli (ATCC® 8739TM), Pseudomonas aeruginosa (ATCC® 9027TM) and Staphylococcus aureus (ATCC® 6538TM) were tested against the same antibiotics as control microorganisms (25).

3.1 Physicochemical Measurements of Sampling Areas

Temperature, pH, conductivity and hardness values of water samples are shown in Table I. The air temperature of the sample areas A, B, C (Figure 1) was determined. The temperature of area A was 9.8°C and that of B and C were determined as 9.4°C. The moisture value was evaluated as 93% in all these areas. The Parsık cave resembles most cave systems with its high level of humidity and stable air temperature (26, 27). It was determined that the pH and hardness values of the waters at points B and C were higher than those at point A. These details highlight the differences in chemical environment that may exist within the cave areas.

Table I

Physicochemical Measurements of Water Samples

Measured values Water sample areas
A point B point C point
pH 8.2 9.8 9.8
Hardness, ppt 0.107 0.145 0.145
Conductivity, mS 0.22 0.30 0.30
Temperature, °C 10 9.2 9.2

3.2 Number of Determined Total (Live/Dead) Bacteria

The highest vitality percentage of bacteria isolated in soil samples was found in samples from point B with 38.7%, whereas the highest vitality percentage in the water samples was found in samples from point C with 26.3% (Table II). In cave environments, it is observed that bacteria can survive metabolically but cannot be cultured. This is because bacteria enter a viable but nonculturable cell form under extreme environmental conditions such as low or high temperature, nutrient deficiency, osmolarity and light. In addition, cave microorganisms obtain their energy from the cave atmosphere or the cave surfaces to which they are attached (28, 29).

Table II

Number of Bacteria in Water and Soil Samples According to DAPI/CTC Method

Samples Total number of signals, cm2 Vitality, %
CTC Total
SA 406,505,880 2,947,167,630 13.8
SB 135,501,960 643,634,310 21
SC 508,132,350 1,930,902,930 26.3
TA 1,084,015,680 5,318,451,930 20.3
TB 8,130,117,600 21,002,803,800 38.7
TC 6,097,588,200 20,664,048,900 29.5

3.3 Number and Classification of Culturable Aerobic Heterotrophic Bacteria

SCA, ISP4, SEA and AIA-G have been used especially in surface and soil samples to increase the probability of isolating bacteria belonging to phylum Actinobacteria, which have an extremely high potentials in terms of antimicrobial production (30). TWA and R2A medium were used for both isolation and counting of other bacterial groups. Apart from these media, 1/2 TSA was used for isolation of other bacterial groups from all samples. The cave environment in general is oligotrophic and these media provide a similar environment to the culturable cave bacteria. The number of culturable aerobic heterotrophic bacteria from water and soil samples obtained from R2A and TWA media is given in Figure 2.

Fig. 2

Number of aerobic heterotrophic bacteria that can be cultured from water and soil samples (TA = soil sample A; TB = soil sample B; TC = soil sample C; SA = water sample A; SB = water sample B; SC = water sample C)

Number of aerobic heterotrophic bacteria that can be cultured from water and soil samples (TA = soil sample A; TB = soil sample B; TC = soil sample C; SA = water sample A; SB = water sample B; SC = water sample C)

When the bacterial counts of water and soil samples in R2A and TWA media were examined, the highest bacterial numbers were found in R2A medium. These results were evaluated statistically using the Kruskal-Wallis test. The p value was found to be 0.09 and no significant difference was found between the numbers of bacteria grown on the R2A and TWA media. In a study conducted in 2014 (31), the efficiency of various media (SEA, TWA, SCA, TSA) was compared to their suitability for bacterial counting. Efficient results for both isolation and counting were obtained in TWA.

A total of 372 bacteria were isolated from all samples. VITEK® analysis was applied to only 321 bacteria which had different characteristics in culture-based analyses. The results of the systematic classification of the bacteria were compiled by biochemical analysis using the VITEK® 2 Compact 30 automated system. Actinobacteria (33%) was determined to be the dominant phylum in this study while the other determined phyla were Firmicutes (25%) and Proteobacteria (16%). In our previous work in Kadıini cave in Turkey, the dominant phylum was Firmicutes (86%), followed by Proteobacteria (12%) and Actinobacteria (2%) respectively (32). In addition, in the study done by Tomova et al. (33), Proteobacteria (51.45%) were found to be the dominant phylum in the samples taken from the Magura cave, Bulgaria, followed by Actinobacteria (43.68%) and Bacteroidetes (3.88%). Although the bacterial habitat of each cave is specific, Proteobacteria, Actinobacteria, Bacteroidetes and Firmicutes are the most identified groups in culture-based microbiological studies in caves (3436).

In our study, Firmicutes was the most common phylum in soil samples with a rate of 33%, while the most common phylum determined in surface and water isolates was Actinobacteria with 36% and 35% respectively. Considering all the samples, at the class level, Actinobacteria was the most dominant with 33%, while Bacilli with 23% was detected as the second dominant class. It was demonstrated through previous studies that Actinobacteria existed mainly in cave walls, soil, sediment and on speleothem surfaces, which might have considerably contributed to the formation of cave structures and the biomineralisation in the cave ecosystems (437). Actinobacteria as well as Firmicutes are frequent among the microbial population inhabiting the caves. Compared to the Proteobacteria group, Firmicutes are more resistant to stress caused by dehydration as well as restriction of nutrients (37). Contrary to our findings for Parsık cave, Proteobacteria are a dominant group in heterotrophic bacterial communities in many caves (33, 34, 3840). In the current study, Proteobacteria were determined respectively as 10%, 21% and 17% in the surface, water and soil samples. The dominant classes of this phylum were found to be Gammaproteobacteria and Alphaproteobacteria with 9.2% and 6.4%, respectively. In our previous study in Kadıini cave, Alphaproteobacteria were detected at 2%, while Gammaproteobacteria were at 9% (32). The phylum Proteobacteria, having a key role in biogeochemical cycles, and being abundant in samples from cave sediment, soil, dripping water and cave surface, is a cosmopolitan bacterial group (37).

3.4 Enzymatic Reactions of Parsık Cave Bacteria

Enzymatic reactions of microorganisms give us ideas of their metabolic activities which are related to their environment. The biochemical tests of our isolates in the VITEK® system were not only useful for bacterial identification but also to provide more information about nutrients in Parsık cave. In addition, results of these tests were used to evaluate the potentials of the isolates for biotechnological uses in terms of their enzyme production. 76 Gram-negative bacteria, 194 Gram-positive and 51 Gram-positive spore forming bacteria have been tested using the GN, GP and BCL cards respectively in the VITEK® 2 compact device, and results are given in Figure 3, Figure 4 and Figure 5 respectively. Most of the isolates displayed peptidase (arylamidase) while only Gram-negative bacteria (less than 10%) showed lipolytic activity. In the study conducted in Gumki cave, India, 75.5% of bacteria produced lipase, 47% were amylase producers and 24% produced protease (41). Another study screening cave bacteria for enzyme production found 40% lipase and 87% protease producers (33). This variation in enzymatic profiles in cave bacteria reinforces the idea that every cave is unique.

Fig. 3

Biochemical properties of Gram-negative bacteria. Tests for Gram-negative bacteria by VITEK® 2 Compact 30 micro device. See Glossary in main text for explanation of terms

Biochemical properties of Gram-negative bacteria. Tests for Gram-negative bacteria by VITEK® 2 Compact 30 micro device. See Glossary in main text for explanation of terms

Fig. 4

Biochemical properties of Gram-positive bacteria. Tests for Gram-positive bacteria by VITEK® 2 Compact 30 micro device. See Glossary in main text for explanation of terms

Biochemical properties of Gram-positive bacteria. Tests for Gram-positive bacteria by VITEK® 2 Compact 30 micro device. See Glossary in main text for explanation of terms

Fig. 5

Biochemical properties of Gram-positive Bacilli bacteria. Tests for Gram-positive Bacilli bacteria by VITEK® 2 Compact 30 micro device. See Glossary in main text for explanation of terms

Biochemical properties of Gram-positive Bacilli bacteria. Tests for Gram-positive Bacilli bacteria by VITEK® 2 Compact 30 micro device. See Glossary in main text for explanation of terms

The high activity of amino acids arylamidase determined in our tested isolates indicates their potential for protein catabolism (42). The phyla Firmicutes (31%) and Actinobacteria (30.7%) produced the highest amounts of arylamidases identified among the tested isolates. 85.52%, 65.97% and 82.35% of Gram-negative, Gram-positive and Gram-positive spore forming bacilli revealed tyrosine-arylamidase activity. Tyrosine is a non-essential amino acid which is synthesised through phenylalanine hydrolysis. It plays a major role in most enzyme synthesis as reported by Kalkan and Altuğ (42), since it is the phosphate and sulfate receptor of protein kinase during protein synthesis. It is also used to reinforce the activity of proteins as demonstrated in a study conducted in thrombin inhibitors showing that tyrosine sulfation could open a way for the development of an anti-thrombotic drug (43). Hence, tyrosine arylamidase has a valuable role in biotechnology since it contributes to the liberation of the amino acid tyrosine.

Enzymes like leucine arylamidase have been reported to be important in food processing industries and the treatment of waste products (44, 45). The degradation of leucine and other amino acids results in volatile molecules responsible for the flavours of some foods like meat products as reported by Papamanoli et al. (46) and Lee et al. (44). In addition, a study showed the roles of bacteria in conversion of paper mill sludge demonstrating the important contribution of amino acid peptidase with leucine arylamidase (45). In our study, 81.95% and 88.23% of Gram-positive bacteria and Gram-positive bacilli showed leucine arylamidase activity. This enzyme was the second most produced enzyme, after the tyrosine arylamidase, by our isolates. Bacteria which can produce this enzyme could be used directly or indirectly by using their enzymes in both composting of sludge and fermentation of food products such as meat and dairy products.

VITEK® results have showed that some Parsık cave isolates exhibit beta-galactosidase activity which is the more expressed carbohydrate hydrolase in this study. Considering the whole of the tested isolates, most of the bacteria producing beta-galactosidase belong to the Firmicutes phylum with 40.6%, while only 10.9% of beta-galactosidase producers were classified under the phylum Proteobacteria.

The main role of the beta-galactosidase enzyme is to convert lactose into monosaccharides. Glucose and galactose resulting from this reaction not only contribute to the development of the cell but can also be used in dairy product processing (44, 47). This enzyme is important since it solves the problem of human lactose intolerance. The hydrolysation of lactose by this enzyme results in molecules like galactooligosaccharides which have health benefits as prebiotics (47). Moreover, breakdown of some sugars like D-mannose, D-mannitol and D-glucose by fermentation was reported, especially in Gram-negative bacteria.

Lipolytic activity was also observed in some of our isolated Gram-negative bacteria (less than 10%). Even if it was produced by a minimum number of isolates, the activity of lipase was fully expressed by bacteria belonging to the phylum Proteobacteria. This class of enzymes which is used in hydrolysation of lipids could be important in bioremediation since it could participate in oil degradation. Sharma et al. reported that microbial lipases are best for biodiesel production (48). Since they can use all types of free fatty acids and glycerides, they exhibit a high activity, thermostability, alcohol resistance, less reaction time as well as less production inhibition (48). Other enzymes were produced by some of the bacteria in Parsık caves. Further studies should be carried out to clarify them and assess their biotechnological uses.

3.5 Antimicrobial Agent Production Capability

Microorganisms with broad-spectrum bioactive components, antifungal and antibacterial agents in cave-specific habitats are common in these extreme environments (17). In our study, a total of 129 cave bacteria were tested for their antimicrobial effect against nine different standard bacterial strains and one fungal strain. Experiments have shown that 10 of the selected bacteria (six from Actinobacteria class, four from Bacilli class) have antimicrobial effects against the standard strains.

Parsık cave isolates displayed variable inhibition rates against the tested microorganisms and the highest inhibition rate was observed against Candida albicans. Some of our cave isolates have been found to have inhibitory effects against S. aureus, S. epidermidis, VRE and P. aeruginosa. The zone diameters of cave bacteria with antimicrobial properties against tested microorganisms are shown in Table III.

Table III

Antimicrobial Agent Production Ability

Isolates/classes of bacteria Resulting zone diameters, mm
E. coli E. faecalis B. subtilis S. aureus S. epidermidis MRSA VRE P. aeruginosa K. pneumoniae Candida albicans
SA22/Actinobacteria 9
TA44/Actinobacteria 16
TA12/Actinobacteria 13.5
SA56/Actinomycetes 13
TB48/Bacilli 13
SB1/Bacilli 30
TA62/Actinomycetes 24
TB27/Bacilli 15
SC3/Bacilli 30
TB64/Actinobacteria 13
Antibiotics
Piperacillin 11 24 19 13 20 9 31 16 22 ND
Vancomycin 16 13 8 10 21 18 ND
Gentamicin 11 6.5 16 8 13 20 11 22 ND
Tetracycline 10 16 8 14 14 5 19 ND
Rifampicin 7 16 17 10 18 35 28 8 15 ND
Ofloxacin 15 18 21 13 15 31 30 23 35 ND

In our study, the isolate which affected S. epidermidis belongs to the Bacilli class and those which inhibit VRE and S. aureus belong to the Actinobacteria class. Some studies have shown that bacteria with antimicrobial activity inhabiting karst caves are often from the Actinobacteria class (30, 31). However, cave bacteria belonging to phyla Proteobacteria, Firmicutes (especially Bacilli class) and Bacteroides were determined to have antimicrobial and bioactive substances. Thus, approximately 50% of the bacteria isolated from the Magura cave, Bulgaria were detected to inhibit the increase of P. aeruginosa (33). Cave bacteria inhibiting MRSA and VRE clinical strains were determined in a study on Actinomycetes isolated from 19 different caves in Turkey (30). Certainly the bacteria belonging to the class Actinobacteria are the best known in terms of antimicrobial material synthesis, but the isolation of bacteria belonging to the other classes is very important especially in karst environments.

3.6 Determination of Antibiotic Resistance Profiles of Isolated Bacteria

Antibiotic resistant bacteria are widespread in several environments. In this study, resistance to 10 different antibiotics of 101 bacteria (76% Gram-positive; 25% Gram-negative) selected from the cave isolates was investigated. Isolates with a metabolic reaction rate of at least 95% similarities to the data in the VITEK® database were selected.

When the antibiotic resistance profiles of the isolates were examined, 7% of the bacteria belonging to the cave were resistant to all antibiotics. The highest number of bacteria showed resistance against ampicillin with a rate of 38.6%. In addition, 35.6% of the isolates showed resistance against two or more antibiotics.

Antibiotic resistance profiles of Gram-positive and Gram-negative cave isolates are shown in Figure 6. The lowest resistance was observed to rifampicin (9% for Gram-positive and 8% for Gram-negative). In parallel with our study, it was determined that all the Pajsarjeva jama, Slovenia, isolates were sensitive to rifampicin (49). Likewise, low levels of resistance to ofloxacin, which is a DNA/RNA synthesis inhibitor like rifampicin, were observed in Parsık cave isolates (11% in Gram-positive and 12% in Gram-negative). The resistance rate of Pajsarjeva jama isolates to erythromycin was 73.6% for Gram-negative and 39% for Gram-positive bacteria. The resistance of Parsik cave isolates to erythromycin was determined at lower levels of 20% and 21% for Gram-negative and Gram-positive bacteria respectively. The levels of resistance to protein synthesis inhibitors other than erythromycin (gentamycin, neomycin, tetracycline and chloramphenicol) were determined to range from 12% to 20% for both Gram-positive and Gram-negative bacteria. Contrary to our study, Lavoie et al. (50) showed that cave isolates were highly resistant to gentamycin, neomycin and chloramphenicol antibiotics (33–66% for Gram-negative bacteria and 61–83% for Gram-positive bacteria).

Fig. 6

Resistance levels of Parsık cave bacteria against various antibiotics which are grouped according to their mode of action: (a) Gram-positive isolates; (b) Gram-negative isolates

Resistance levels of Parsık cave bacteria against various antibiotics which are grouped according to their mode of action: (a) Gram-positive isolates; (b) Gram-negative isolates

Furthermore, the lowest resistance to cell wall synthesis inhibitors was observed in piperacillin for both Gram-positive (12%) and Gram-negative (16%) bacteria. In the study conducted by Lavoie et al. (50), the resistance to piperacillin, compared to other antibiotic resistance, was found to be lower (average 37.5%).

In our study, considering the cell wall synthesis inhibitors (vancomycin and ampicillin), Gram-negative bacteria were found to be more resistant than the Gram-positive ones. Similar to our study, Avguštin et al. (49) revealed that cave Gram-negative isolates showed higher resistance to ampicillin.

According to VITEK® results, except ampicillin and vancomycin, Actinobacteria were determined to be the most resistant (47–70%) phylum to all tested antibiotics. The highest resistance to ampicillin and vancomycin was observed in the phylum Proteobacteria. Like the microbial diversity of caves, antibiotic resistance is also variable. While the antibiotic resistance rates were high, no isolate producing antimicrobial agent was detected in the study conducted by Lavoie et al. (50). However, one of the antibiotic resistance hypotheses in caves is that there is a high rate of antibiotic resistance in the presence of microorganisms producing antimicrobial agents. Studies have shown that bacteria having antibiotic genes can also produce antimicrobial agents (51, 52). In our study, it was found that 50% of the isolates producing antimicrobial agents were resistant to at least two antibiotics. Therefore, study of bacterial antibiotic resistance may contribute to the development of new antibiotics. To clarify this issue, studies in this issue should be continued.

By |2020-10-01T15:46:14+00:00October 1st, 2020|Weld Engineering Services|Comments Off on The Biotechnological Potentials of Bacteria Isolated from Parsık Cave, Turkey
Go to Top